L. Castano and G. Eisenbarth, Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and Rat, Annual Review of Immunology, vol.8, issue.1, pp.647-679, 1990.
DOI : 10.1146/annurev.iy.08.040190.003243

M. Atkinson and N. Maclaren, The pathogenesis of insulin-dependent diabetes mellitus, N Engl J Med, vol.331, pp.1428-1436, 1994.

J. Bach, Insulin-Dependent Diabetes Mellitus as an Autoimmune Disease, Endocrine Reviews, vol.15, issue.4, pp.516-542, 1994.
DOI : 10.1210/edrv-15-4-516

D. Devendra, E. Liu, and G. Eisenbarth, Type 1 diabetes: recent developments, BMJ, vol.328, issue.7442, pp.750-754, 2004.
DOI : 10.1136/bmj.328.7442.750

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC381328/pdf

P. Onkamo, S. Vaananen, M. Karvonen, and J. Tuomilehto, Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends, Diabetologia, vol.42, issue.12, pp.1395-1403, 1999.
DOI : 10.1007/s001250051309

J. Yoon, A new look at viruses in type 1 diabetes, Diabetes / Metabolism Reviews, vol.39, issue.1, pp.83-108, 1995.
DOI : 10.1042/bst0181264

D. Devendra and G. Eisenbarth, Interferon alpha???a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity, Clinical Immunology, vol.111, issue.3, pp.225-233, 1995.
DOI : 10.1016/j.clim.2004.01.008

H. Hyoty and K. Taylor, The role of viruses in human diabetes, Diabetologia, vol.45, pp.1353-1361, 2002.

X. Huang, J. Yuan, A. Goddard, A. Foulis, R. James et al., Interferon Expression in the Pancreases of Patients With Type I Diabetes, Diabetes, vol.44, issue.6, pp.658-664, 1995.
DOI : 10.2337/diab.44.6.658

T. Stewart, Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases, Cytokine & Growth Factor Reviews, vol.14, issue.2, pp.139-154, 2003.
DOI : 10.1016/S1359-6101(02)00088-6

Y. Stauffer, S. Marguerat, F. Meylan, C. Ucla, N. Sutkowski et al., Interferon-??-Induced Endogenous Superantigen, Immunity, vol.15, issue.4, pp.591-601, 2001.
DOI : 10.1016/S1074-7613(01)00212-6

URL : https://doi.org/10.1016/s1074-7613(01)00212-6

P. Fabris, C. Betterle, N. Greggio, R. Zanchetta, E. Bosi et al., Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis, Journal of Hepatology, vol.28, issue.3, pp.514-517, 1998.
DOI : 10.1016/S0168-8278(98)80328-0

X. Huang, B. Hultgren, N. Dybdal, and T. Stewart, Islet expression of interferon-?? precedes diabetes in both the BB rat and streptozotocin-treated mice, Immunity, vol.1, issue.6, pp.469-478, 1994.
DOI : 10.1016/1074-7613(94)90089-2

D. Sobel, J. Newsome, C. Ewel, J. Bellanti, V. Abbassi et al., Poly I:C Induces Development of Diabetes Mellitus in BB Rat, Diabetes, vol.41, issue.4, pp.515-520, 1992.
DOI : 10.2337/diab.41.4.515

V. Thomas, B. Woda, E. Handler, D. Greiner, J. Mordes et al., Altered Expression of Diabetes in BB/Wor Rats by Exposure to Viral Pathogens, Diabetes, vol.40, issue.2, pp.255-258, 1991.
DOI : 10.2337/diab.40.2.255

D. Serreze, K. Hamaguchi, and E. Leiter, Immunostimulation circumvents diabetes in NODLt mice, Journal of Autoimmunity, vol.2, issue.6, pp.759-776, 1989.
DOI : 10.1016/0896-8411(89)90003-6

N. Abiru, A. Maniatis, L. Yu, D. Miao, H. Moriyama et al., Peptide and Major Histocompatibility Complex-Specific Breaking of Humoral Tolerance to Native Insulin With the B9-23 Peptide in Diabetes-Prone and Normal Mice, Diabetes, vol.50, issue.6, pp.1274-1281, 2001.
DOI : 10.2337/diabetes.50.6.1274

H. Moriyama, L. Wen, N. Abiru, E. Liu, L. Yu et al., Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide, Proceedings of the National Academy of Sciences, vol.76, issue.1, pp.5539-5544, 2002.
DOI : 10.2337/diab.41.8.1016

J. Paronen, E. Liu, H. Moriyama, D. Devendra, A. Ide et al., Genetic differentiation of Poly I:C from B:9-23 peptide induced experimental autoimmune diabetes, Journal of Autoimmunity, vol.22, issue.4, pp.307-313, 2004.
DOI : 10.1016/j.jaut.2004.01.006

URL : https://hal.archives-ouvertes.fr/pasteur-01643774

T. Stewart, B. Hultgren, X. Huang, S. Pitts-meek, J. Hully et al., Induction of type I diabetes by interferon-alpha in transgenic mice, Science, vol.260, issue.5116, pp.1942-1946, 1993.
DOI : 10.1126/science.8100367

C. Asselin-paturel, A. Boonstra, M. Dalod, I. Durand, N. Yessaad et al., Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology, Nature Immunology, vol.95, issue.12, pp.1144-1150, 2001.
DOI : 10.1006/clim.2000.4858

L. Wen, J. Peng, Z. Li, and F. Wong, The Effect of Innate Immunity on Autoimmune Diabetes and the Expression of Toll-Like Receptors on Pancreatic Islets, The Journal of Immunology, vol.172, issue.5, pp.3173-3180, 2004.
DOI : 10.4049/jimmunol.172.5.3173

S. Guerder, D. Picarella, P. Linsley, and R. Flavell, Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice., Proceedings of the National Academy of Sciences, vol.91, issue.11, pp.5138-5142, 1994.
DOI : 10.1073/pnas.91.11.5138

S. Guerder, J. Meyerhoff, and R. Flavell, The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen, Immunity, vol.1, issue.2, pp.155-166, 1994.
DOI : 10.1016/1074-7613(94)90109-0

D. Harlan, H. Hengartner, M. Huang, Y. Kang, R. Abe et al., Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness., Proceedings of the National Academy of Sciences, vol.91, issue.8, pp.3137-3141, 1994.
DOI : 10.1073/pnas.91.8.3137

K. Lang, M. Recher, T. Junt, A. Navarini, N. Harris et al., Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease, Nature Medicine, vol.168, issue.2, pp.138-145, 2005.
DOI : 10.4049/jimmunol.168.12.6032

URL : https://infoscience.epfl.ch/record/143011/files/2005_Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.pdf

I. Krause, G. Valesini, R. Scrivo, and Y. Shoenfeld, Autoimmune aspects of cytokine and anticytokine therapies, The American Journal of Medicine, vol.115, issue.5, pp.390-397, 2003.
DOI : 10.1016/S0002-9343(03)00390-5

J. Steegmann, M. Requena, P. Martin-regueira, D. L. Camara, R. Casado et al., High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-??, American Journal of Hematology, vol.14, issue.3, pp.170-176, 2003.
DOI : 10.1046/j.1440-1746.1999.01896.x

C. Fabbri, M. Jaboli, S. Giovanelli, F. Azzaroli, A. Pezzoli et al., Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy, World Journal of Gastroenterology, vol.9, issue.7, pp.1487-1490, 2003.
DOI : 10.1006/jaut.1999.0360

URL : http://doi.org/10.3748/wjg.v9.i7.1487

D. Preziati, L. Rosa, L. Covini, G. Marcelli, R. Rescalli et al., Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a, European Journal of Endocrinology, vol.132, issue.5, pp.587-593, 1995.
DOI : 10.1530/eje.0.1320587

F. Shimizu, M. Shimizu, and K. Kamiyama, Inhibitory Effect of Interferon on the Production of Insulin, Endocrinology, vol.117, issue.5, pp.2081-2084, 1985.
DOI : 10.1210/endo-117-5-2081

C. Rhodes and K. Taylor, Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets, Diabetologia, vol.132, issue.6, pp.601-603, 1984.
DOI : 10.1007/BF00276977

V. Bonnevie-nielsen, P. Martensen, J. Justesen, K. Kyvik, B. Kristensen et al., The Antiviral 2???,5???-Oligoadenylate Synthetase Is Persistently Activated in Type 1 Diabetes, Clinical Immunology, vol.96, issue.1, pp.11-18, 2000.
DOI : 10.1006/clim.2000.4874

J. Hooks, H. Moutsopoulos, S. Geis, N. Stahl, J. Decker et al., Immune Interferon in the Circulation of Patients with Autoimmune Disease, New England Journal of Medicine, vol.301, issue.1, pp.5-8, 1979.
DOI : 10.1056/NEJM197907053010102

W. Chehadeh, J. Weill, M. Vantyghem, G. Alm, J. Lefebvre et al., Increased Level of Interferon????? in Blood of Patients with Insulin???Dependent Diabetes Mellitus: Relationship with Coxsackievirus B Infection, The Journal of Infectious Diseases, vol.181, issue.6, pp.1929-1939, 2000.
DOI : 10.1086/315516

A. Foulis, M. Farquharson, and R. Hardman, Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus, Diabetologia, vol.320, issue.Suppl 1, pp.333-343, 1987.
DOI : 10.1007/BF00299027